Amgen's first quarter 2014 revenues increased 7 percent to $4.5 billion
Amgen reported total revenues increased 7 percent in the 2014 first quarter to $4,521 million versus $4,238 reported in the same 2013 quarter. Adjusted operating income increased 18 percent to $1,860 million, driven by a significant increase in the profitability of Enbrel®. April 22, 2014